Home Lilly profit beats analyst estimates as Cymbalta sales climb
 

Keywords :   


Lilly profit beats analyst estimates as Cymbalta sales climb

2013-01-29 16:01:20| Biotech - Topix.net

Eli Lilly and Co.'s fourth quarter earnings slipped 4 percent as generic competition continued to eat away at sales of its former best-seller, the antipsychotic Zyprexa, but the drugmaker cut expenses again and growth from other products helped it beat analyst expectations.

Tags: sales profit estimates analyst

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11Tropical Depression Thirteen-E Forecast Discussion Number 1
01.11Tropical Depression Thirteen-E Graphics
01.11Tropical Depression Thirteen-E Wind Speed Probabilities Number 1
01.11Summary for Tropical Depression Thirteen-E (EP3/EP132024)
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11CERM launches new MIS products, Mark Andy innovates and more
01.11Removing a major trade barrier: Full access to Colombia restored for U.S. beef
More »